+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Enteral Feeding Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • ID: 4520160
  • Report
  • April 2022
  • Region: Global
  • 186 Pages
  • Mordor Intelligence

FEATURED COMPANIES

  • Abbott Laboratories
  • Amsino International Inc.
  • B. Braun Melsungen AG
  • Conmed Corporation
  • Fidmi Medical
  • Halyard Health Inc.

The enteral feeding devices market was valued at USD 3,735.79 million in 2021 and is expected to reach USD 5,451.06 million by 2027, registering a CAGR of 6.50% over the forecast period.



The current pandemic of COVID-19 is expected to significantly impact the enteral feeding devices market globally. According to the research article published in Critical Care, 2020, the SARS-CoV2 virus infects the respiratory tract and is also predicted to invade the gastrointestinal tract, neurological systems, and kidneys, which may affect the nutrition delivery among COVID-19 patients. According to the guidelines by the European Society for Clinical Nutrition and Metabolism (ESPEN) on nutrition in the ICU, Gastric Enteral Nutrition is advised for severe COVID-19 patients and should be preferably performed using a pump with a flow regulator, within 48 hours of admission to the ICU. Hence, the COVID-19 pandemic has increased the need for enteral feeding devices, especially for those in intensive care units, and thus, has been driving the studied market.



The factors that are responsible for the growth of the market include the rising burden of chronic diseases, the increasing number of premature deaths, and the growing demand for enteral feeding in-home care settings.



The rising burden of chronic diseases is a major factor driving the market growth. For instance, as per the GLOBOCAN 2020, an estimated number of 1.09 million new stomach cancer cases were identified in 2020 globally and the number is estimated to reach 1.77 million by the year 2040. As patients suffering from stomach cancer require the support of enteral nutrition, the statistics indicate that the demand for enteral feeding devices is anticipated to increase in the coming period. As per a 2022 update by the International Foundation for Gastrointestinal Disorders (IFFGD), 10 to 15% of the population is affected by irritable bowel syndrome, worldwide. Thus, the high burden of chronic diseases is leading to an increased demand for enteral feeding devices, thereby contributing to market growth.



However, complications associated with enteral feeding tubes and healthcare reimbursement issues are the major factors restraining the market growth.



Key Market Trends


Diabetes Segment is Expected to Witness a Significant Growth During the Forecast Period


By application, the diabetes segment is expected to witness significant growth during the forecast period. The major factors fueling the growth of the segment are the increasing burden of diabetes, the growing geriatric population, and the increasing implementation of strategic initiatives by the market players.



For instance, incidences of diabetes have increased over the years globally and are expected to increase further. As per a 2021 update by the International Diabetes Federation (IDF), approximately 537 million adults (20-79 years) are living with diabetes. As per the same source, the total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045. The source also reports that 1 in 4 adults with diabetes live in low- and middle-income countries and almost 1 in 2 (240 million) adults living with diabetes are undiagnosed.



Several market players are also engaged in the implementation of strategic initiatives, thereby contributing to market growth. For instance, in July 2021, Medtronic Diabetes received approval from the Food and Drug Administration (FDA) for its extended-wear infusion set, designed to last more than twice as long as existing infusion sets that connect traditional tubed pumps to the body for insulin delivery.



Thus, these factors play a major role in increasing the demand for enteral feeding devices, which will likely boost market growth.



North America is Expected to Dominate the Enteral Feeding Devices Market Over the Forecast Period


The North American region, particularly the United States has a developed and well-structured health care system. The region is a hub for research and development activities and encourages key players to establish their headquarters in the region through its policies and investment support. As a result, these countries enjoy the presence of many global market players.



The growing burden of chronic diseases and the geriatric population in the region and surgical procedures is expected to drive the demand for enteral feeding devices, to support the nutritional requirements of individuals who can not ingest and digest food. For instance, as per the 2020 statistics by the United States Department of Health and Human Services, approximately 39,034 liver transplants were performed in the United States in 2020. As enteral nutrition support is required in patients undergoing liver transplantation, the statistics indicate the significant demand for enteral feeding devices in the country.



Additionally, as per the statistics by the IDF Diabetes Atlas, 10th Edition, in 2021, the number of people identified with diabetes, in thousands, was 32,215.3 in the United States and the number is estimated to reach 36,289.9 by the year 2045. Diabetes patients are likely to have a threefold elevated risk of being hospitalized. Many of the consequences of improperly managed diabetes, such as stroke, can necessitate enteral feeding. Thus, the statistics indicate the increasing demand for enteral feeding devices in the country.



Moreover, market players are engaged in various strategies that are contributing to market growth. For instance, in May 2021, QMD has reported the addition of Nasogastric Tubes to the Degania Enteral Feeding Product Portfolio. The Nasogastric Tubes are manufactured from premium materials and designed to comply with ENFit connection standards for improved patient safety.



Thus, due to the above-mentioned developments, the market is expected to witness significant growth over the forecast period.



Competitive Landscape


The enteral feeding devices market is highly competitive. In terms of market share, several companies, such as B. Braun Melsungen AG, Boston Scientific Corporation, Conmed Corporation, Cardinal Health, and Becton Dickinson and Company, among others, hold the largest market shares. The key players are evolving through various strategic alliances, such as acquisitions, collaborations, and new product launches, to expand the global product portfolio and secure their positions in the global market.



Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support


This product will be delivered within 2 business days.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Amsino International Inc.
  • B. Braun Melsungen AG
  • Conmed Corporation
  • Fidmi Medical
  • Halyard Health Inc.

1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Burden of Chronic Diseases
4.2.2 Increasing Number of Premature Births
4.2.3 Growing Demand for Enteral Feeding in Home Care Settings
4.3 Market Restraints
4.3.1 Complications Associated with Enteral Feeding Tubes
4.3.2 Healthcare Reimbursement Issues
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Value- USD million)
5.1 By Product Type
5.1.1 Enteral Feeding Pumps
5.1.2 Enteral Feeding Tubes
5.1.3 Other Product Types
5.2 By Age Group
5.2.1 Adults
5.2.2 Pediatrics
5.3 By End User
5.3.1 Hospitals
5.3.2 Ambulatory Care Services
5.3.3 Other End Users
5.4 By Application
5.4.1 Oncology
5.4.2 Neurology
5.4.3 Critical Care
5.4.4 Diabetes
5.4.5 Gastroenterology
5.4.6 Other Applications
5.5 Geography
5.5.1 North America
5.5.1.1 United States
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.2 Europe
5.5.2.1 Germany
5.5.2.2 United Kingdom
5.5.2.3 France
5.5.2.4 Italy
5.5.2.5 Spain
5.5.2.6 Rest of Europe
5.5.3 Asia-Pacific
5.5.3.1 China
5.5.3.2 Japan
5.5.3.3 India
5.5.3.4 Australia
5.5.3.5 South Korea
5.5.3.6 Rest of Asia-Pacific
5.5.4 Middle East and Africa
5.5.4.1 GCC
5.5.4.2 South Africa
5.5.4.3 Rest of Middle East and Africa
5.5.5 South America
5.5.5.1 Brazil
5.5.5.2 Argentina
5.5.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 B. Braun Melsungen AG
6.1.3 Boston Scientific Corporation
6.1.4 Conmed Corporation
6.1.5 Cook Medical Inc.
6.1.6 Fresenius SE & Co. KGaA
6.1.7 Halyard Health Inc.
6.1.8 Nestle SA
6.1.9 Avanos Medical, Inc.
6.1.10 Cardinal Health, Inc.
6.1.11 Becton Dickinson and Company
6.1.12 Vygon SA
6.1.13 Applied Medical technology, Inc.
6.1.14 Amsino International Inc.
6.1.15 Fidmi Medical
6.1.16 ALCOR Scientific, Inc.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Conmed Corporation
  • Cook Medical Inc.
  • Fresenius SE & Co. KGaA
  • Halyard Health Inc.
  • Nestle SA
  • Avanos Medical, Inc.
  • Cardinal Health, Inc.
  • Becton Dickinson and Company
  • Vygon SA
  • Applied Medical technology, Inc.
  • Amsino International Inc.
  • Fidmi Medical
  • ALCOR Scientific, Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...